Orally active benzodiazepine derivatives represented by the structures defined in the specification and their salts are disclosed. These compounds and their salts have anxiolytic and anticonvulsant activity with reduced sedative/hypnotic/muscle relaxant/ataxic effects.
Anxiolytic agents with reduced sedative and ataxic effects